BioSpace News Archive

Hutchison China MediTech Limited

The two companies start development program to integrate Sensome’s tissue micro-sensor into Asahi’s world class guidewire

Inflazome announces that the United States Patent and Trademark Office and the European Patent Office will grant the patent application WO 2016/131098 as US 10,538,487 on 21 January 2020 and EP 3,259,253 on 15 January 2020.

Ambrx Inc. and Sino Biopharmaceutical Limited announced a joint collaboration to develop two products enabled by Ambrx’s unique non-natural amino acid incorporation technology platforms.

The HDR InfiniBand Connected Supercomputer Will Increase the Center’s Weather and Climate Research Compute Power by Five Times, Enabling Enhanced and Far More Accurate Forecast and Predictions

Neuropore Therapies, Inc. announced that it has successfully completed the Phase 1 clinical trial in healthy volunteers with NPT520-34.

Itamar Medical Ltd. reported preliminary unaudited revenue results for the fourth quarter and full year ended December 31, 2019 and announced revenue guidance for the full year 2020.

Axsome Therapeutics, Inc. has entered into an agreement with Pfizer Inc. for an exclusive U.S. license to Pfizer’s clinical and nonclinical data, and intellectual property for reboxetine, the active pharmaceutical ingredient in AXS-12 which Axsome is developing for the treatment of narcolepsy.

Increasing BCMA Surface Expression with Gamma Secretase Inhibitor Nirogacestat May Enable Deep and Durable Responses to ALLO-715, an Investigational Anti-BCMA Allogeneic CAR T Therapy

New research findings presented in November at the Italian Cancer Society’s 61st annual meeting in Naples, Italy confirm the ability of Phoenix Biotechnology’s drug PBI-05204 to act synergistically with coadministration of temozolamide and radiotherapy to kill Glioblastoma Multiforme in mice with orthotopically implanted human GBM cells.